Explore the latest advances in RSV vaccine research, and what these developments mean for prevention and public health.

Researchers found that RSV protein subunit vaccines probably reduce RSV-related hospitalization (vaccine efficacy, 83.3%) and severe RSV illness (vaccine efficacy, 94.1%) in older adults. HealthDay ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

Discover how arbovirus E Dimer vaccines are engineered to improve safety by minimizing antibody dependent enhancement.